Correlation Between Catalyst Pharmaceuticals and Vine Hill

Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Vine Hill at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Vine Hill into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Catalyst Pharmaceuticals and Vine Hill Capital, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Vine Hill and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Vine Hill. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Vine Hill.

Diversification Opportunities for Catalyst Pharmaceuticals and Vine Hill

-0.61

Correlation Coefficient

Catalyst Pharmaceuticals  Vine Hill

Excellent diversification

The 3 months correlation between Catalyst and Vine is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Vine Hill Capital in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vine Hill Capital and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Vine Hill. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vine Hill Capital has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Vine Hill go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and Vine Hill

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 22.43 times more return on investment than Vine Hill. However, Catalyst Pharmaceuticals is 22.43 times more volatile than Vine Hill Capital. It trades about 0.11 of its potential returns per unit of risk. Vine Hill Capital is currently generating about 0.23 per unit of risk. If you would invest  2,060  in Catalyst Pharmaceuticals on September 16, 2024 and sell it today you would earn a total of  78.00  from holding Catalyst Pharmaceuticals or generate 3.79% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Catalyst Pharmaceuticals  vs.  Vine Hill Capital

Catalyst Pharmaceuticals

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Catalyst Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Vine Hill Capital

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Vine Hill Capital are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound forward indicators, Vine Hill is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Catalyst Pharmaceuticals and Vine Hill

The main advantage of trading using opposite Catalyst Pharmaceuticals and Vine Hill positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Vine Hill can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vine Hill will offset losses from the drop in Vine Hill's long position.

The idea behind Catalyst Pharmaceuticals and Vine Hill Capital pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.